Hologic (HOLX) Has a Women’s-Health and Diagnostics Platform Story Bigger Than the Post-COVID Comedown

[ad_1] Hologic (HOLX) is easy to misread if investors anchor on what happened after the COVID testing surge faded. That lens reduces the company to a comedown story in diagnostics. The better way to view Hologic is as a women’s-health…







